In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs.
AAPS PharmSciTech
; 21(5): 153, 2020 May 24.
Article
in English
| MEDLINE | ID: covidwho-343702
ABSTRACT
The supply of affordable, high-quality pharmaceuticals to US patients has been on a critical path for decades. In and beyond the COVID-19 pandemic, this critical path has become tortuous. To regain reliability, reshoring of the pharmaceutical supply chain to the USA is now a vital national security need. Reshoring the pharmaceutical supply with old know-how and outdated technologies that cause inherent unpredictability and adverse environmental impact will neither provide the security we seek nor will it be competitive and affordable. The challenge at hand is complex akin to redesigning systems, including corporate and public research and development, manufacturing, regulatory, and education ones. The US academic community must be engaged in progressing solutions needed to counter emergencies in the COVID-19 pandemic and in building new methods to reshore the pharmaceutical supply chain beyond the pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Viral Vaccines
/
Civil Defense
/
Coronavirus Infections
/
Needs Assessment
/
Pandemics
/
Betacoronavirus
/
Health Services Needs and Demand
Type of study:
Observational study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
AAPS PharmSciTech
Journal subject:
Pharmacology
Year:
2020
Document Type:
Article
Affiliation country:
S12249-020-01718-9
Similar
MEDLINE
...
LILACS
LIS